New faster-acting and more effective treatments for Hepatitis C are transforming treatment - offering a cure for, and even eradication of, the potentially fatal infection.
Silja Chouquet examines the Twitter noise at pharma meetings and offers pointers to keep KOLs engaged while avoiding the attention of worthless click-farm accounts.
Following on from her first article investigating how physicians make decisions, Theano Anastasopoulou explains how cognitive biases can influence the ways new drugs are promoted.
In the first of two articles, Theano Anastasopoulou uses behavioural economics to understand and investigate how physicians make decisions and thereby improve the take-up of new medicines.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.